FDA — authorised 2 September 1976
- Application: ANDA084535
- Marketing authorisation holder: LANNETT
- Local brand name: BENZYL BENZOATE
- Indication: EMULSION — TOPICAL
- Status: approved
🇺🇸 Ascabin in United States
FDA authorised Ascabin on 2 September 1976
Marketing authorisations
FDA
- Status: approved
Ascabin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Ascabin approved in United States?
Yes. FDA authorised it on 2 September 1976; FDA has authorised it.
Who is the marketing authorisation holder for Ascabin in United States?
LANNETT holds the US marketing authorisation.